Scarica l'app Stockscreener
4.00
5.26%
0.20
Precedente Chiudi:
$3.80
Aprire:
$3.82
Volume 24 ore:
429.37K
Relative Volume:
1.59
Capitalizzazione di mercato:
$189.95M
Reddito:
$114.70K
Utile/perdita netta:
$-37.06M
Rapporto P/E:
-1.0018
EPS:
-3.9929
Flusso di cassa netto:
$-30.69M
1 W Prestazione:
+1.27%
1M Prestazione:
+25.79%
6M Prestazione:
+117.99%
1 anno Prestazione:
+34.68%
Intervallo 1D:
$3.8075
$4.08
Intervallo di 1 settimana:
$3.58
$4.08
Portata 52W:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Nome
Sab Biotherapeutics Inc
Settore
Industria
Telefono
305-845-2813
Indirizzo
777 W 41ST ST, MIAMI BEACH
Confronta SABS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
3.99 | 180.91M | 114.70K | -37.06M | -30.69M | -3.9929 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.65 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
720.65 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.06 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
903.07 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.93 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Leerink Partners | Outperform |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-10-09 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-05 | Iniziato | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Borsa (SABS) Ultime notizie
Institution Moves: Is Above Food Ingredients Inc. stock safe for conservative investorsNew Guidance & Technical Pattern Based Buy Signals - BỘ NỘI VỤ
Why analysts upgrade SAB Biotherapeutics Inc. Equity Warrant stockQuarterly Portfolio Review & Safe Swing Trade Setups - Newser
Will SAB Biotherapeutics Inc. Equity Warrant stock gain from lower inflationMarket Movers & Consistent Growth Equity Picks - Newser
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
How SAB Biotherapeutics Inc. stock performs in rate cut cyclesWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
Will SAB Biotherapeutics Inc. Equity Warrant stock reach Wall Street targetsTrade Analysis Report & Daily Volume Surge Signals - Newser
Is SAB Biotherapeutics Inc. Equity Warrant stock a buy before product launchesEarnings Overview Report & Daily Technical Stock Forecast Reports - Newser
Weekly Recap: What margin trends mean for SAB Biotherapeutics Inc. stockMarket Performance Summary & Low Volatility Stock Recommendations - moha.gov.vn
How SAB Biotherapeutics Inc. Equity Warrant stock trades before earnings2025 EndofYear Setup & Short-Term High Return Strategies - BỘ NỘI VỤ
The growth track for SAB Biotherapeutics Inc (SABS) has changed recently - Setenews
Will SAB Biotherapeutics Inc. stock benefit from green energy trendsEarnings Risk Summary & Accurate Entry/Exit Alerts - BỘ NỘI VỤ
Leerink Partnrs Has Optimistic View of SABS FY2025 Earnings - MarketBeat
Research Analysts Set Expectations for SABS FY2025 Earnings - Defense World
Q1 Earnings Forecast for SABS Issued By Leerink Partnrs - Defense World
SAB Biotherapeutics Inc Stock Analysis and ForecastEx-Dividend Date Alerts & Low Cost Stock Picks - earlytimes.in
SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners are individual investors who got richer after stock soared 22% last week - Yahoo Finance
SABS Q4 EPS Forecast Lifted by Brookline Capital Management - Defense World
We Think SAB Biotherapeutics (NASDAQ:SABS) Can Afford To Drive Business Growth - Sahm
SAB Biotherapeutics Inc. (SABS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What risks investors should watch in SAB Biotherapeutics Inc. stockQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
Will SAB Biotherapeutics Inc. stock reach Wall Street targets2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
Trend analysis for SAB Biotherapeutics Inc. Equity Warrant this weekDollar Strength & AI Powered Market Entry Ideas - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock outperform Dow Jones indexWeekly Volume Report & Growth Focused Investment Plans - newser.com
Is SAB Biotherapeutics Inc. forming a reversal patternJuly 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Why SAB Biotherapeutics Inc. stock remains a top recommendationBond Market & AI Based Buy/Sell Signal Reports - newser.com
Is SAB Biotherapeutics Inc. stock safe for conservative investors2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Using Bollinger Bands to evaluate SAB Biotherapeutics Inc. Equity WarrantRate Hike & Weekly Watchlist of Top Performers - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant reversing from oversold territoryAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Will SAB Biotherapeutics Inc. stock deliver better than expected guidanceWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
What risks investors should watch in SAB Biotherapeutics Inc. Equity Warrant stockPortfolio Update Report & Reliable Price Breakout Alerts - newser.com
SAB Biotherapeutics Reports Positive Q3 2025 Earnings - MSN
SAB Biotherapeutics, Inc. Warrant 2021-22.10.26 on SAB Biotherap - TradingView
What sentiment indicators say about SAB Biotherapeutics Inc. stock2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
Ranking SAB Biotherapeutics Inc. Equity Warrant among high performing stocks via tools2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock is considered a top pickJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant a candidate for recovery playJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Chardan Capital Reiterates “Buy” Rating for SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sab Biotherapeutics Inc Azioni (SABS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director |
Sep 29 '25 |
Option Exercise |
1.75 |
1,740,000 |
3,045,000 |
2,198,457 |
0.72%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):